Immunomodulation by vitamin D: implications for TB

References

• Holick MF. Vitamin D deficiency. N. Engl. J. Med.357(3), 266–281 (2007).
   PubMed Web of Science ®Google Scholar
• Adams JS, Hewison M. Update in vitamin D. J. Clin. Endocrinol. Metab.95(2), 471–478 (2010).
   PubMed Web of Science ®Google Scholar
• DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr.80(Suppl. 6), 1689S–1696S (2004).
   PubMed Web of Science ®Google Scholar
• Bouillon R, Bischoff-Ferrari H, Willett W. Vitamin D and health: perspectives from mice and man. J. Bone Miner. Res.23(7), 974–979 (2008).
   PubMed Web of Science ®Google Scholar
• Bikle DD, Siiteri PK, Ryzen E, Haddad JG. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels. J. Clin. Endocrinol. Metab.61(5), 969–975 (1985).
   PubMed Web of Science ®Google Scholar
• Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J. Clin. Endocrinol. Metab.63(4), 954–959 (1986).
   PubMed Web of Science ®Google Scholar
• Nykjaer A, Dragun D, Walther D et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell96(4), 507–515 (1999).
   PubMed Web of Science ®Google Scholar
• Bikle DD, Gee E. Free, and not total, 1,25-dihydroxyvitamin D regulates 25-hydroxyvitamin D metabolism by keratinocytes. Endocrinology124(2), 649–654 (1989).
   PubMed Web of Science ®Google Scholar
• Chun RF, Lauridsen AL, Suon L et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab.95(7), 3368–3376 (2010).
   PubMed Web of Science ®Google Scholar
• Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology149(7), 3656–3667 (2008).
   PubMed Web of Science ®Google Scholar
• MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C. Vitamin D receptor and nuclear receptor coactivators: crucial interactions in vitamin D-mediated transcription. Steroids66(3–5), 171–176 (2001).
   PubMed Web of Science ®Google Scholar
• Pike JW, Meyer MB, Watanuki M et al. Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. J. Steroid Biochem. Mol. Biol.103(3–5), 389–395 (2007).
   PubMedGoogle Scholar
• Adams JS, Gacad MA. Characterization of 1 α-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J. Exp. Med.161(4), 755–765 (1985).
   PubMed Web of Science ®Google Scholar
• Dusso A, Brown A, Slatopolsky E. Extrarenal production of calcitriol. Semin. Nephrol.14(2), 144–155 (1994).
   PubMedGoogle Scholar
• Farooque A, Moss C, Zehnder D, Hewison M, Shaw NJ. Expression of 25-hydroxyvitamin D3–1α-hydroxylase in subcutaneous fat necrosis. Br. J. Dermatol.160(2), 423–425 (2009).
   PubMedGoogle Scholar
• Zehnder D, Bland R, Williams MC et al. Extrarenal expression of 25-hydroxyvitamin D(3)-1 α-hydroxylase. J. Clin. Endocrinol. Metab.86(2), 888–894 (2001).
   PubMed Web of Science ®Google Scholar
• Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol.10(4), 482–496 (2010).
   PubMed Web of Science ®Google Scholar
• Maruotti N, Cantatore FP. Vitamin D and the immune system. J. Rheumatol.37(3), 491–495 (2010).
   PubMed Web of Science ®Google Scholar
• Hewison M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol. Metab. Clin. North Am.39(2), 365–379 (2010).
   PubMed Web of Science ®Google Scholar
• Grad R. Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharm. Hist.46(3), 106–120 (2004).
   PubMedGoogle Scholar
• Rook GA, Steele J, Fraher L et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology57(1), 159–163 (1986).
   PubMed Web of Science ®Google Scholar
• Koeffler HP, Reichel H, Bishop JE, Norman AW. γ-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem. Biophys. Res. Commun.127(2), 596–603 (1985).
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Li H et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science311(5768), 1770–1773 (2006).
   PubMed Web of Science ®Google Scholar
• Nelson CD, Reinhardt TA, Beitz DC, Lippolis JD. In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection. PloS one5(11), e15469 (2010).
   PubMed Web of Science ®Google Scholar
• Wang TT, Nestel FP, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol.173(5), 2909–2912 (2004).
   PubMed Web of Science ®Google Scholar
• Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J.19(9), 1067–1077 (2005).
   PubMed Web of Science ®Google Scholar
• Adams JS, Ren S, Liu PT et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J. Immunol.182(7), 4289–4295 (2009).
   PubMed Web of Science ®Google Scholar
• Gombart AF, Saito T, Koeffler HP. Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics10, 321 (2009).
   PubMed Web of Science ®Google Scholar
• Liu PT, Schenk M, Walker VP et al. Convergence of IL-1β and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PloS one4(6), e5810 (2009).
   PubMed Web of Science ®Google Scholar
• Wang TT, Dabbas B, Laperriere D et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-β defensin 2 innate immune pathway defective in Crohn’s disease. J. Biol. Chem.285(4), 2227–2231 (2010).
   PubMed Web of Science ®Google Scholar
• Crotzer VL, Blum JS. Autophagy and adaptive immunity. Immunology131(1), 9–17 (2010).
   PubMed Web of Science ®Google Scholar
• Jo EK. Innate immunity to mycobacteria: vitamin D and autophagy. Cell. Microbiol.12(8), 1026–1035 (2010).
   PubMed Web of Science ®Google Scholar
• Levine B, Mizushima N, Virgin HW. Autophagy in immunity and inflammation. Nature469(7330), 323–335 (2011).
   PubMed Web of Science ®Google Scholar
• Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell119(6), 753–766 (2004).
   PubMed Web of Science ®Google Scholar
• Deretic V, Delgado M, Vergne I et al. Autophagy in immunity against Mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy. Curr. Top. Microbiol. Immunol.335, 169–188 (2009).
   PubMed Web of Science ®Google Scholar
• Yuk JM, Shin DM, Lee HM et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe6(3), 231–243 (2009).
   PubMed Web of Science ®Google Scholar
• Shin DM, Yuk JM, Lee HM et al. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signaling. Cell. Microbiol.12(11), 1648–1665 (2010).
   PubMed Web of Science ®Google Scholar
• Sly LM, Lopez M, Nauseef WM, Reiner NE. 1α,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J. Biol. Chem.276(38), 35482–35493 (2001).
   PubMed Web of Science ®Google Scholar
• Yang CS, Shin DM, Kim KH et al. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J. Immunol.182(6), 3696–3705 (2009).
   PubMed Web of Science ®Google Scholar
• Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med.175(4), 1111–1122 (1992).
   PubMed Web of Science ®Google Scholar
• MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA94(10), 5243–5248 (1997).
   PubMed Web of Science ®Google Scholar
• Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR, Lapa e Silva JR et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med.183(5), 2293–2302 (1996).
   PubMed Web of Science ®Google Scholar
• Waters WR, Palmer MV, Nonnecke BJ, Whipple DL, Horst RL. Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. Microb. Pathog.36(1), 11–17 (2004).
   PubMed Web of Science ®Google Scholar
• Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun.66(11), 5314–5321 (1998).
   PubMed Web of Science ®Google Scholar
• Rivas-Santiago B, Hernandez-Pando R, Carranza C et al. Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells. Infect. Immun.76(3), 935–941 (2008).
   PubMed Web of Science ®Google Scholar
• Martineau AR, Wilkinson KA, Newton SM et al. IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J. Immunol.178(11), 7190–7198 (2007).
   PubMed Web of Science ®Google Scholar
• Edfeldt K, Liu PT, Chun R et al. T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc. Natl. Acad. Sci. USA107(52), 22593–22598 (2010).
   PubMed Web of Science ®Google Scholar
• Krutzik SR, Hewison M, Liu PT et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol.181(10), 7115–7120 (2008).
   PubMed Web of Science ®Google Scholar
• Harris J, Hope JC, Keane J. Tumor necrosis factor blockers influence macrophage responses to Mycobacterium tuberculosis.J. Infect. Dis.198(12), 1842–1850 (2008).
   PubMed Web of Science ®Google Scholar
• Master SS, Rampini SK, Davis AS et al.Mycobacterium tuberculosis prevents inflammasome activation. Cell Host Microbe3(4), 224–232 (2008).
   PubMed Web of Science ®Google Scholar
• Schaible UE, Sturgill-Koszycki S, Schlesinger PH, Russell DG. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol.160(3), 1290–1296 (1998).
   PubMed Web of Science ®Google Scholar
• Via LE, Fratti RA, McFalone M, Pagan-Ramos E, Deretic D, Deretic V. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci.111(Pt 7), 897–905 (1998).
   PubMedGoogle Scholar
• Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin. Exp. Immunol.161(1), 1–9 (2010).
   PubMed Web of Science ®Google Scholar
• Shi CS, Kehrl JH. TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci. Signal.3(123), ra42 (2010).
   PubMed Web of Science ®Google Scholar
• Harris J, De Haro SA, Master SS et al. T helper 2 cytokines inhibit autophagic control of intracellular. Mycobacterium tuberculosis Immunity27(3), 505–517 (2007).
   Google Scholar
• Karmali R, Hewison M, Rayment N et al. 1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology74(4), 589–593 (1991).
   PubMedGoogle Scholar
• Nunn JD, Katz DR, Barker S et al. Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology59(4), 479–484 (1986).
   PubMedGoogle Scholar
• Provvedini DM, Manolagas SC. 1 A,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J. Clin. Endocrinol. Metab.68(4), 774–779 (1989).
   PubMed Web of Science ®Google Scholar
• Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J. Steroid Biochem. Mol. Biol.53(1–6), 599–602 (1995).
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Yu S, Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol. Aspects Med.29(6), 369–375 (2008).
   PubMed Web of Science ®Google Scholar
• Overbergh L, Decallonne B, Waer M et al. 1α,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524–543). Diabetes.49(8), 1301–1307 (2000).
   PubMed Web of Science ®Google Scholar
• Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1α,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol.167(9), 4974–4980 (2001).
   PubMed Web of Science ®Google Scholar
• Harris J, Master SS, De Haro SA et al. Th1–Th2 polarisation and autophagy in the control of intracellular mycobacteria by macrophages. Vet. Immunol. Immunopathol.128(1–3), 37–43 (2009).
   PubMedGoogle Scholar
• Salgame P. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr. Opin. Immunol.17(4), 374–380 (2005).
   PubMed Web of Science ®Google Scholar
• Abebe F, Bjune G. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin. Exp. Immunol.157(2), 235–243 (2009).
   PubMed Web of Science ®Google Scholar
• Lin PL, Flynn JL. Understanding latent tuberculosis: a moving target. J. Immunol.185(1), 15–22 (2010).
   PubMed Web of Science ®Google Scholar
• Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr. Allergy Asthma Rep.11(1), 29–36 (2011).
   PubMed Web of Science ®Google Scholar
• Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 α,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol.167(4), 1945–1953 (2001).
   PubMed Web of Science ®Google Scholar
• Barrat FJ, Cua DJ, Boonstra A et al.In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med.195(5), 603–616 (2002).
   PubMed Web of Science ®Google Scholar
• Gorman S, Kuritzky LA, Judge MA et al. Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J. Immunol.179(9), 6273–6283 (2007).
   PubMed Web of Science ®Google Scholar
• Dong X, Bachman LA, Kumar R, Griffin MD. Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transpl. Immunol.11(3–4), 323–333 (2003).
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G, Giarratana N et al. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J. Steroid Biochem. Mol. Biol.89–90(1–5), 437–441 (2004).
   PubMed Web of Science ®Google Scholar
• Urry Z, Xystrakis E, Richards DF et al. Ligation of TLR9 induced on human IL-10-secreting Tregs by 1α,25-dihydroxyvitamin D3 abrogates regulatory function. J. Clin. Invest.119(2), 387–398 (2009).
   PubMed Web of Science ®Google Scholar
• Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1α,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes51(5), 1367–1374 (2002).
   PubMed Web of Science ®Google Scholar
• Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol. Metab.16(6), 261–266 (2005).
   PubMed Web of Science ®Google Scholar
• Spach KM, Nashold FE, Dittel BN, Hayes CE. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol.177(9), 6030–6037 (2006).
   PubMed Web of Science ®Google Scholar
• Chen X, Zhou B, Li M et al. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin. Immunol.123(1), 50–59 (2007).
   PubMed Web of Science ®Google Scholar
• Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol.6(11), 1123–1132 (2005).
   PubMed Web of Science ®Google Scholar
• Liu N, Nguyen L, Chun RF et al. Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology149(10), 4799–4808 (2008).
   PubMedGoogle Scholar
• Chang SH, Chung Y, Dong C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J. Biol. Chem.285(50), 38751–38755 (2010).
   PubMed Web of Science ®Google Scholar
• Colin EM, Asmawidjaja PS, van Hamburg JP et al. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum.62(1), 132–142 (2010).
   PubMed Web of Science ®Google Scholar
• Wozniak TM, Saunders BM, Ryan AA, Britton WJ. Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infect. Immun.78(10), 4187–4194 (2010).
   PubMed Web of Science ®Google Scholar
• Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J. Infect. Dis.201(1), 20–31 (2010).
   PubMedGoogle Scholar
• Wejse C, Olesen R, Rabna P et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am. J. Clin. Nutr.86(5), 1376–1383 (2007).
   PubMed Web of Science ®Google Scholar
• Williams B, Williams AJ, Anderson ST. Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr. Infect. Dis. J.27(10), 941–942 (2008).
   PubMed Web of Science ®Google Scholar
• Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J. Infect.50(5), 432–437 (2005).
   PubMed Web of Science ®Google Scholar
• Wilkinson RJ, Llewelyn M, Toossi Z et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case–control study. Lancet355(9204), 618–621 (2000).
   PubMed Web of Science ®Google Scholar
• Talat N, Perry S, Parsonnet J, Dawood G, Hussain R. Vitamin D deficiency and tuberculosis progression. Emerg. Infect. Dis.16(5), 853–855 (2010).
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B et al. Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J. Bone Miner. Res.24(5), 935–942 (2009).
   PubMed Web of Science ®Google Scholar
• Ross AC, Manson JE, Abrams SA et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab.96(1), 53–58 (2011).
   PubMed Web of Science ®Google Scholar
• Martineau AR, Honecker FU, Wilkinson RJ, Griffiths CJ. Vitamin D in the treatment of pulmonary tuberculosis. J. Steroid Biochem. Mol. Biol.103(3–5), 793–798 (2007).
   PubMed Web of Science ®Google Scholar
• Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int. J. Epidemiol.37(1), 113–119 (2008).
   PubMed Web of Science ®Google Scholar
• Martineau AR, Wilkinson RJ, Wilkinson KA et al. A single dose of vitamin D enhances immunity to mycobacteria. Am. J. Respir. Crit. Care Med.176(2), 208–213 (2007).
   PubMed Web of Science ®Google Scholar
• Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med. Indones.38(1), 3–5 (2006).
   PubMedGoogle Scholar
• Martineau AR, Timms PM, Bothamley GH et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet377(9761), 242–250 (2011).
   PubMed Web of Science ®Google Scholar
• Wejse C, Gomes VF, Rabna P et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med.179(9), 843–850 (2009).
   PubMed Web of Science ®Google Scholar
• Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene338(2), 143–156 (2004).
   PubMed Web of Science ®Google Scholar
• Arai H, Miyamoto K, Taketani Y et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J. Bone Miner. Res.12(6), 915–921 (1997).
   PubMed Web of Science ®Google Scholar
• Zhang HQ, Deng A, Guo CF et al. Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. Arch. Med. Res.41(1), 46–49 (2010).
   PubMed Web of Science ®Google Scholar
• Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int. J. Tuberc. Lung Dis.14(1), 15–23 (2010).
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Baker I, Davey Smith G. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int. J. Tuberc. Lung Dis.9(10), 1174–1177 (2005).
   PubMed Web of Science ®Google Scholar
• Soborg C, Andersen AB, Range N et al. Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol. Immunol.44(9), 2213–2220 (2007).
   PubMed Web of Science ®Google Scholar
• Schaaf MJ, Cidlowski JA. AUUUA motifs in the 3’UTR of human glucocorticoid receptor α and β mRNA destabilize mRNA and decrease receptor protein expression. Steroids67(7), 627–636 (2002).
   PubMed Web of Science ®Google Scholar
• Ates O, Dolek B, Dalyan L, Musellim B, Ongen G, Topal-Sarikaya A. The association between BsmI variant of vitamin D receptor gene and susceptibility to tuberculosis. Mol. Biol. Rep.38(4), 2633–2636 (2011).
   PubMed Web of Science ®Google Scholar
• Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum. Genet.92(2), 183–188 (1993).
   PubMed Web of Science ®Google Scholar
• Kamboh MI, Ferrell RE. Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations. Hum. Genet.72(4), 281–293 (1986).
   PubMed Web of Science ®Google Scholar
• Wang TJ, Zhang F, Richards JB et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet376(9736), 180–188 (2010).
   PubMed Web of Science ®Google Scholar
• Ahn J, Yu K, Stolzenberg-Solomon R et al. Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet.19(13), 2739–2745 (2010).
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Kumashiro R. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells. J. Immunol.151(5), 2794–2802 (1993).
   PubMed Web of Science ®Google Scholar
• Mohamad SB, Nagasawa H, Uto Y, Hori H. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities. Anticancer Res.22(6C), 4297–4300 (2002).
   PubMedGoogle Scholar
• Wood AM, Bassford C, Webster D et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax66(3), 205–210 (2011).
   PubMed Web of Science ®Google Scholar
• Martineau AR, Leandro AC, Anderson ST et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur. Respir. J. (2009).
   PubMedGoogle Scholar
• Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann. Epidemiol. (2008).
   PubMedGoogle Scholar
• Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos. Int.16(7), 713–716 (2005).
   PubMed Web of Science ®Google Scholar
• Dunn JF. Computer simulation of vitamin D transport. Ann. NY Acad. Sci.538, 69–76 (1988).
   PubMedGoogle Scholar
• Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin. Chem.47(4), 753–756 (2001).
   PubMed Web of Science ®Google Scholar
• Gibney KB, MacGregor L, Leder K et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin. Infect. Dis.46(3), 443–446 (2008).
   PubMed Web of Science ®Google Scholar